Elecsys β-CrossLaps/serum
Classification
- Category
- Immunoassay & Serology
- Technology
- Chemiluminescence Immunoassay
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.
The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-06
2026-10-28
availability varies